COCRYSTAL PHARMA, INC. Current Assets
COCRYSTAL PHARMA, INC. (COCP) had Current Assets of $3.24 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $3.24M.
- 2026-03-31: Assets, Current $5.94M.
- 2025-12-31: Assets, Current $8.13M.
- 2025-09-30: Assets, Current $8.78M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.24M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.94M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $8.13M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.78M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $6.76M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $8.83M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $11.58M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $14.26M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $19.66M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $24.49M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $29.09M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $32.20M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $35.76M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $37.24M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $40.18M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $44.90M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $51.60M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $55.40M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $59.32M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $62.44M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $67.34M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $33.69M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $34.02M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $32.90M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $20.10M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $22.58M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $8.28M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $7.01M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.53M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $9.87M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.94M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $4.99M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $7.10M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.48M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.18M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $2.88M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.94M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $3.10M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $5.47M 10-K · filed 2018-03-21 | |
| 2016-09-30 | $6.75M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.94M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $10.92M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $9.92M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $13.22M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $16.33M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $15.75M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $6.38M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $5.80M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $10.10M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $10.04M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.17M 10-K · filed 2015-03-31 | $6.46M 10-K · filed 2014-03-31 |
| 2013-09-30 | $2.83M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $3.57M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $2.52M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $6.69M 10-K · filed 2014-03-31 | $2.67M 10-K · filed 2013-04-01 |
| 2012-09-30 | $3.64M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.37M 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $3.24M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $2.90M 10-K · filed 2013-04-01 | |
| 2011-09-30 | $6.06M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $6.44M 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $4.19M 10-K · filed 2012-04-16 | $4.20M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |